Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Tolazamide measurement |
Component |
True |
Tolazamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Tolazamide adverse reaction |
Causative agent (attribute) |
True |
Tolazamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to tolazamide |
Causative agent (attribute) |
False |
Tolazamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tolazamide 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tolazamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tolazamide 250 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tolazamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing tolazamide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tolazamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely tolazamide 500 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tolazamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to tolazamide |
Causative agent (attribute) |
True |
Tolazamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Tolazamide 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tolazamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Tolazamide 100 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Tolazamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Tolazamide 250 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tolazamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Tolazamide 250 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Tolazamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely tolazamide 500 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tolazamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely tolazamide 500 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Tolazamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Tolazamide 100 mg oral tablet |
Has precise active ingredient |
True |
Tolazamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Tolazamide 250 mg oral tablet |
Has precise active ingredient |
True |
Tolazamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely tolazamide 500 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Tolazamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing tolazamide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tolazamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only tolazamide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tolazamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Tolazamide only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tolazamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |